Cargando…
Upregulated osterix promotes invasion and bone metastasis and predicts for a poor prognosis in breast cancer
Approximately 70% of patients with advanced breast cancer develop bone metastases, accompanied by complications, such as bone pain, fracture, and hypercalcemia. However, our understanding of the molecular mechanisms that govern this process remains fragmentary. Osterix (Osx) is a zinc finger-contain...
Autores principales: | Yao, Bing, Wang, Jue, Qu, Shuang, Liu, Yang, Jin, Yuci, Lu, Jianlei, Bao, Qianyi, Li, Lingyun, Yuan, Hongyan, Ma, Changyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328543/ https://www.ncbi.nlm.nih.gov/pubmed/30631043 http://dx.doi.org/10.1038/s41419-018-1269-3 |
Ejemplares similares
-
Correction to: Upregulated osterix promotes invasion and bone metastasis and predicts for a poor prognosis in breast cancer
por: Yao, Bing, et al.
Publicado: (2022) -
Osterix promotes the migration and angiogenesis of breast cancer by upregulation of S100A4 expression
por: Qu, Shuang, et al.
Publicado: (2018) -
MiR‐664‐3p suppresses osteoblast differentiation and impairs bone formation via targeting Smad4 and Osterix
por: Xu, Yuexin, et al.
Publicado: (2021) -
Osterix acetylation at K307 and K312 enhances its transcriptional activity and is required for osteoblast differentiation
por: Lu, Jianlei, et al.
Publicado: (2016) -
Characterization of Osterix Protein Stability and Physiological Role in Osteoblast Differentiation
por: Peng, Yanyan, et al.
Publicado: (2013)